Ochre Bio Revenue and Competitors
Estimated Revenue & Valuation
- Ochre Bio's estimated annual revenue is currently $10.1M per year.
- Ochre Bio's estimated revenue per employee is $155,000
Employee Data
- Ochre Bio has 65 Employees.
- Ochre Bio grew their employee count by 3% last year.
Ochre Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CSO, Co-founder | Reveal Email/Phone |
2 | Head Research, Oxford | Reveal Email/Phone |
3 | VP Translational Development | Reveal Email/Phone |
4 | Director, In Silico Biology | Reveal Email/Phone |
5 | Director, Programme Management | Reveal Email/Phone |
6 | Director, Preclinical Development | Reveal Email/Phone |
7 | Director, Corporate Strategy and Business Development | Reveal Email/Phone |
8 | Associate Director | Reveal Email/Phone |
9 | Research Associate II | Reveal Email/Phone |
10 | Research Associate II | Reveal Email/Phone |
Ochre Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Ochre Bio?
Many donor livers are too unhealthy or damaged to be transplanted and so go to waste, even though one in six patients die waiting for a new liver. The main reason for discarding a donor liver is that it contains too much fat. At Ochre we develop genomic medicines that rejuvenate transplanted livers, ultimately with the goal of applying these therapies to treat fatty liver disease (NASH/NAFL) and other cardiometabolic diseases. We employ spatial sequencing, advanced genomics, and high-throughput screening to identify disease-causing genes, and develop combination therapies which are tested in donor livers kept alive outside of the body. Our scientific roots can be traced back over 15 years leading liver genomics research, and experience in bringing advanced therapies to market. Privately held, Ochre Bio is situated within the heart of Oxford's biotech innovation hub. To learn more, please visit www.ochre-bio.com.
keywords:N/A
N/A
Total Funding
65
Number of Employees
$10.1M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ochre Bio News
LifeShare Oklahoma partners with OrganOx and Ochre Bio to study perfusion ... LifeShare of Oklahoma has recently partnered with Ochre Bio,...
But finding financing for Ochre Bio was a little tougher than he ... with fellow first-time founder Nabiha Saklayen, CEO of Cellino Bio.
Other Companies in Oxford
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12.3M | 65 | 5% | N/A |
#2 | $13.3M | 67 | -12% | N/A |
#3 | $8.4M | 67 | 2% | N/A |
#4 | $8.7M | 67 | 68% | N/A |
#5 | $15M | 68 | 19% | N/A |